174 results on '"Brosjö O"'
Search Results
2. GM-CSF at Relatively high topic concentrations can significantly enhance the healing of surgically induced chronic wounds after radiotherapy
3. Use of99mTc-MIBI scintigraphy in the evaluation of the response of osteosarcoma to chemotherapy
4. POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands#
5. Identification of a novel amplicon at distal 17q containing the BIRC5/SURVIVIN gene in malignant peripheral nerve sheath tumours
6. Soft-tissue fat tumours : differentiating malignant from benign using proton density fat fraction quantification MRI.
7. Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders
8. Fine needle aspiration (FNA) cytology in the diagnosis of recurrent soft tissue sarcoma
9. MR IMAGING OF SKELETAL MUSCLE HEMANGIOMAS: A report of 16 cases
10. Osteosarcoma Management and Interferon
11. Fetthaltiga mjukdelstumörer i rörelseapparaten ofta godartade
12. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups
13. A comparison of Indomethacin and Diclofenac in the inhibition of experimental heterotopic new bone formation
14. Intra-Articular Synovial Sarcomas: Incidence and Differentiating Features from Localized Pigmented Villonodular Synovitis
15. POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands
16. POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands.
17. Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis.
18. Chemotherapy in osteosarcoma: The Scandinavian Sarcoma Group experience
19. Chemotherapy in Ewing's sarcoma: The Scandinavian Sarcoma Group experience
20. Telomeric associations correlate with telomere length reduction and clonal chromosome aberrations in giant cell tumor of bone
21. Identification of a novel amplicon at distal 17q containing theBIRC5/SURVIVINgene in malignant peripheral nerve sheath tumours
22. Chemotherapy in Ewing's sarcomaThe Scandinavian Sarcoma Group experience
23. Chemotherapy in osteosarcomaThe Scandinavian Sarcoma Group experience
24. Fine needle aspiration cytology in the diagnosis and management of children and adolescents with Ewing sarcoma and peripheral primitive neuroectodermal tumor*
25. GM-CSF at Relatively High Topic Concentrations Can Significantly Enhance the Healing of Surgically Induced Chronic Wounds after Radiotherapy
26. Use of 99m Tc-MIBI scintigraphy in the evaluation of the response of osteosarcoma to chemotherapy
27. CYTOLOGICAL DIAGNOSIS OF BONE TUMOURS
28. Expression of deoxycytidine kinase and phosphorylation of 2-chlorodeoxyadenosine in human normal and tumour cells and tissues
29. Scandinavian experience in classical osteosarcoma: results of the SSG XIV protocol.
30. Diagnostic procedures and surgical treatment of bone sarcomas.
31. Chemotherapy in osteosarcoma.
32. Fine needle aspiration cytology in the diagnosis and management of children and adolescents with Ewing sarcoma and peripheral primitive neuroectodermal tumor*.
33. Experimental Induction of Heterotopic Bone
34. Use of [sup 99m] Tc-MIBI scintigraphy in the evaluation of the response of osteosarcoma to chemotherapy.
35. Osteoid osteoma in a 1-year-old boy -- a case report.
36. Use of <SUP>99m</SUP>Tc-MIBI scintigraphy in the evaluation of the response of osteosarcoma to chemotherapy
37. Retained heterodisomy is associated with high gene expression in hyperhaploid inflammatory leiomyosarcoma
38. Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway.
39. Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma.
40. [Synovial sarcoma - a rare and highly malignant, tumor with an ambiguous clinical picture at times].
41. Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion.
42. Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas.
43. Preoperative radiotherapy of soft-tissue sarcomas: surgical and radiologic parameters associated with local control and survival.
44. Different patterns of clonal evolution among different sarcoma subtypes followed for up to 25 years.
45. EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.
46. The effect of radiotherapy on fat content and fatty acids in myxoid liposarcomas quantified by MRI.
47. Improved Prognosis for Patients with Ewing Sarcoma in the Sacrum Compared with the Innominate Bones: The Scandinavian Sarcoma Group Experience.
48. Current Strategies for the Treatment of Aneurysmal Bone Cysts.
49. Prognostic factors and follow-up strategy for superficial soft-tissue sarcomas: Analysis of 622 surgically treated patients from the scandinavian sarcoma group register.
50. RNA sequencing of sarcomas with simple karyotypes: identification and enrichment of fusion transcripts.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.